Related Experiment Video

Updated: Jun 15, 2026

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

[Evolution of acute myocardial infarction treatment in Argentina from 1987 to 2005]

Jorge G Allín1, Florencia Rolandi, Juan J Herrera Paz

  • 1Hospital Británico, Buenos Aires. jorgeallin@hotmail.com

Medicina
|March 16, 2010
PubMed

Insights

Cardiovascular disease causes one-third of deaths in Argentina, with acute myocardial infarction (AMI) being a major concern. This review compiles available AMI data to improve diagnosis and treatment, despite scarce epidemiological information.

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Context:

  • Cardiovascular diseases are the leading cause of death in Argentina, accounting for one in three fatalities.
  • Acute myocardial infarction (AMI) represents a significant and aggressive health challenge within the country.
  • Existing epidemiological data on AMI in Argentina is limited, often restricted to populations accessing high-complexity healthcare centers.

Purpose:

  • To consolidate and present comprehensive information on acute myocardial infarction (AMI) in Argentina.
  • To address the scarcity of epidemiological data concerning AMI.
  • To equip healthcare professionals with resources for accurate diagnosis and effective therapeutic management of AMI.

Summary:

  • Despite an observed increase in reperfusion rates, mortality from AMI in Argentina has not decreased.
  • This review synthesizes current knowledge on AMI, highlighting diagnostic and therapeutic challenges.
  • The study aims to bridge the gap in epidemiological data for better public health strategies.

Impact:

  • Enhance the understanding and management of AMI in Argentina.
  • Provide a foundation for future epidemiological research and public health interventions.
  • Ultimately contribute to reducing mortality rates associated with acute myocardial infarction.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...